UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 学会が公開する診療ガイドラインのリンク：甲状腺機能亢進症society guideline links hyperthyroidism [show details]
…recommendations for radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I (2011) European Thyroid Association (ETA): Guideline for the management of Graves hyperthyroidism…
2. 学会が公開する診療ガイドラインのリンク：良性と悪性の結節性甲状腺腫society guideline links thyroid nodules and cancer [show details]
…cancer (2012) ATA: Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I – Practice recommendations (2011) European Thyroid Association (ETA): Guidelines regarding thyroid…
3. 学会が公開する診療ガイドラインのリンク：高分化型神経内分泌腫瘍society guideline links well differentiated neuroendocrine tumors [show details]
…English] Japanese Society of Nuclear Medicine (JSNM): Draft guidelines regarding appropriate use of 131I-MIBG radiotherapy for neuroendocrine tumors (2015) [In Japanese] Japanese Association of Endocrine…
4. 切除可能な肝細胞癌のマネージメント：予後、術前補助化学療法と補助化学療法の役割、および治療後サーベイランスmanagement of potentially resectable hepatocellular carcinoma prognosis role of neoadjuvant and adjuvant therapy and posttreatment surveillance [show details]
…of life, and financial cost). Another locoregional approach involves the intraarterial infusion of 131I-labeled lipiodol. Lipiodol (Laboratoire Guerbet, France) is a stable fatty acid ethyl ester derived …
5. 甲状腺機能亢進症の診断diagnosis of hyperthyroidism [show details]
…(123I), then breastfeeding may be resumed ; breastfeeding should not be resumed if the iodine-131 (131I) isotope is used for determining the uptake. From a pathogenetic viewpoint, hyperthyroidism results…

English Journal

Extraordinarily high aldosterone, 901.0 ng/dL, in a patient with primary aldosteronism: an insight into the underlying mechanism.

Okubo Y, Sato Y, Nakasone Y, Shirotori K, Oguchi K, Matsushita T, Nishikawa T, Yamazaki Y, Sasano H, Komatsu M, Yamauchi K, Aizawa T.
Endocrine journal. 2016 ;63(2)127-33.
A 43-yr-old hypertensive male was admitted due to hypokalemia (1.8 mEq/L) and renal dysfunction (eGFR, 20.0 mL/min/1.73 m2). His plasma aldosterone was 901.0 ng/dL, plasma renin activity 5.7 ng/mL/hr, and aldosterone/renin activity ratio 158. Angiotensin II (AII) was 0.7 pg/mL, ACTH <1.0 pg/mL, and
PMID 26549209

A case of adrenal incidentaloma with 131I-adosterol scintigraphy showing high uptake despite no significant physical or endocrinological abnormalities.

Ogo A, Matoba Y, Sakai Y, Hiramatsu S.
Fukuoka igaku zasshi = Hukuoka acta medica. 2010 Jun;101(6)128-31.
PMID 20865902

[Clinical study on postoperative steroid hormone replacement for preclinical Cushing's syndrome].

Furuta N, Koide H, Sasaki H, Miki J, Kimura T, Egawa S.
Nihon Hinyokika Gakkai zasshi. The japanese journal of urology. 2009 Mar;100(3)479-85.
Diagnostic criteria for preclinical Cushing's syndrome (PCS) were reported in 1996. However, requirement of postoperative steroid hormone replacement is still controversial issue. In this study, we observed recent surgical cases retrospectively and evaluate the use of postoperative steroid hormone r
PMID 19348187

Japanese Journal

術前管理に苦慮した肺結核併存原発性アルドステロン症の1例

和久利彦,園部宏
日本臨床外科学会雑誌 75(12), 3348-3353, 2014
症例は68歳，女性．高血圧症のためCa拮抗薬・MR拮抗薬を近医で処方され，正常高値血圧・正常K値を維持していた．他院で肺結核診断後，当院内科入院となり，4剤併用療法開始後，II度高血圧・低K血症を認めた．RFPによるCa拮抗薬の降圧効果減弱を認めたのでARBを追加した．CTで右副腎結節を認め，内分泌検査よりPAが疑われた．内分泌検査のためにMR拮抗薬を一時中止し，薬物代謝酵素誘導の弱いRBTへ変更 …
NAID 130005085350

131I-アドステロールシンチグラフィーが陽性所見の非機能性副腎偶発腫瘍の一例

小河淳,的場ゆか,坂井義之 [他],Hiramatsu Shinsuke
福岡医学雑誌 101(6), 128-131, 2010-06-25
… た．レニンーアルドステロン系や副腎髄質ホルモンは正常であり，以上から非機能性副腎腺腫と診断した．ところが131I-アドステロールシンチグラフィー検査では患側に陽性所見を認めた．この４年間において腫瘍のサイズを含めてこれらの検査所見に著変を認めていない．一般に131I-アドステロールシンチグラフィーの異常集積は機能性副腎腺腫の存在を示唆するが，最近ではプレクリニカルクッ …
NAID 120002451552